key: cord-0280197-iwlreq3f
authors: Shuffrey, L. C.; Firestein, M. R.; Kyle, M.; Fields, A.; Alcantara, C.; Amso, D.; Austin, J.; Bain, J. M.; Barbosa, J.; Bence, M.; Bianco, C.; Fernandez, C.; Goldman, S.; Gyamfi-Bannerman, C.; Hott, V.; Hu, Y.; Hussain, M.; Factor-Litvak, P.; Lucchini, M.; Mandel, A.; Marsh, R.; McBrian, D.; Mourad, M.; Muhle, R.; Noble, K.; Penn, A. A.; Rodriguez, C.; Sania, A.; Silver, W. G.; O Reilly, K. C.; Stockwell, M.; Tottenham, N.; Welch, M. G.; Zork, N.; Fifer, W. P.; Monk, C.; Dumitriu, D.
title: Birth during the COVID-19 pandemic, but not maternal SARS-CoV-2 infection during pregnancy, is associated with lower neurodevelopmental scores at 6-months
date: 2021-07-15
journal: nan
DOI: 10.1101/2021.07.12.21260365
sha: c7e6123564c3db2a27c12a726626f59d51d7f3b1
doc_id: 280197
cord_uid: iwlreq3f

The intrauterine environment strongly influences development. Neurodevelopmental effects of in utero exposure to maternal SARS-CoV-2 infection are widely speculated but currently unknown. The COVID-19 Mother Baby Outcomes (COMBO) initiative was established at Columbia University Irving Medical Center (CUIMC) in New York City to prospectively study the health and wellbeing of infants with and without in utero exposure to maternal SARS-CoV-2 infection. We report findings on 6-month neurodevelopmental outcomes using the parental-report Ages & Stages Questionnaire, 3rd Edition (ASQ-3), from 107 in utero exposed and 131 unexposed full-term infants born between March and December, 2020. We compare these infants to a historical cohort comprised of 62 infants born at CUIMC at least two months prior to the onset of the pandemic. In utero exposure to maternal SARS-CoV-2 infection was not associated with differences on any ASQ-3 subdomain regardless of infection timing or severity, however, infants born during the pandemic had significantly lower scores on gross motor, fine motor, and personal-social subdomains when compared to the historical cohort. Infants born to women who were in the first trimester of pregnancy during the peak of the pandemic in NYC had the lowest personal-social scores. Birth during the pandemic, but not maternal SARS-CoV-2 infection, was associated with differences in neurodevelopmental outcomes at 6-months. These early findings suggest significantly higher public health impact for the generation born during the COVID-19 pandemic than previously anticipated.

Globally, over 200 million infants have been born since the onset of the COVID-19 pandemic. During the first two weeks of universal testing at the height of the pandemic in New York City (NYC), 14% of laboring women in the Columbia University Irving Medical Center (CUIMC) hospital system tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nasopharyngeal polymerase chain reaction (PCR) 1 . To date, 2% of the world's population has been infected at some point during the pandemic. While impossible to precisely quantify, even the most conservative estimates of the total number of infants worldwide with in utero exposures to maternal SARS-CoV-2 infection range in the millions.

Fetal exposure to perturbations of the intrauterine environment is implicated in altered brain development and long-term offspring vulnerability for neurodevelopmental and psychiatric sequelae [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Although vertical transmission of SARS-CoV-2 from mother to fetus is exceedingly rare [16] [17] [18] [19] [20] , data from prior human coronavirus outbreaks (severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS)) suggest that severe infection during pregnancy may not only impact maternal health 21 , but may also increase risk for several adverse infant outcomes through mechanisms related to maternal immune activation 22 . Other viral illnesses during pregnancy are associated with higher risk for neurodevelopmental deficits, including motor delays 23 , as in the case of in utero HIV-exposed uninfected infants [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Additional epidemiological support for this association comes from naturalistic studies of viral epidemics that identified populationlevel impacts. Cohort studies of the generation born during the 1918 H1N1 pandemic found lower child educational attainment and adult socioeconomic status 24 . The 1964 rubella pandemic led to a 10-15fold increase in autism spectrum disorder or schizophrenia in offspring 25, 26 . There is a critical need to determine the neurodevelopmental effects of fetal exposure to maternal SARS-CoV-2 infection 27-31 , especially given the well-established benefits of early identification of at-risk children [32] [33] [34] .

The COVID-19 Mother Baby Outcomes (COMBO) Initiative is a prospective matched casecontrol study established at CUIMC in Spring 2020 to examine the effects of in utero exposure to maternal SARS-CoV-2 infection on the health and wellbeing of both mother and child living in the first U.S. pandemic epicenter (www.ps.columbia.edu/COMBO). Based on evidence from prior studies 23,35,36 , we hypothesized maternal SARS-CoV-2 infection during pregnancy would be associated with delays in social and motor development at 6-months of age. Additionally, we compared infants born during the COVID-19 pandemic to a historical cohort born at the same medical center using the same neurodevelopmental assessment.

This analysis includes infants enrolled in the COMBO Initiative born between March and December, 2020, and an available historical comparison cohort of infants born at the same institution between November, 2017 and January, 2020. Data using the same 6-month postnatal neurodevelopmental measures were available for participants enrolled in both of these cohorts. Preterm delivery (gestational age (GA) <37 weeks) was an exclusionary criteria for the historical cohort; therefore, only full-term COMBO infants were included.

All mother-infant dyads participating in the COMBO Initiative received prenatal care and delivered at the CUIMC-affiliated NewYork-Presbyterian (NYP) Morgan Stanley Children's Hospital (MSCH) or NYP Allen Pavilion Hospital since the onset of the pandemic (first NYC laboring woman diagnosed 3/13/2020 at MSCH). All dyads with a documented SARS-CoV-2 infection during pregnancy (exposed) according to the electronic health record (EHR) were invited to participate and were enrolled during pregnancy or in the first few months postpartum. For each exposed dyad, 1-3 unexposed dyads, defined as the absence of EHR documentation of maternal SARS-CoV-2 infection during pregnancy and at delivery, were matched based on infant sex, GA at birth, mode of delivery, and date of birth (DOB) within a two-week window. Infants included in the historical cohort were recruited from the Well Baby Nursery at MSCH as part of a separate protocol. Study procedures were approved by the CUIMC Institutional Review Board (IRB) for the COMBO cohort and by the New York State Psychiatric Institute IRB for the historical cohort and informed consent was obtained from all participants.

Data at 6-months of age were available for 248 full-term infants enrolled in the pandemic cohort and 3 71 infants enrolled in the historical cohort. Data were excluded from 10 pandemic cohort and 9 historical cohort infants due to completion of the neurodevelopmental assessment outside of the eligibility window. The final sample included data from 300 infants: n=238 in the pandemic cohort (n=107 exposed; n=131 unexposed) and n=62 in the historical cohort.

NYP's hospital practices during the COVID-19 pandemic have been published 37 . Mother-infant separation, which is known to affect neurodevelopmental outcomes 38 , was never implemented. The labor and delivery (L&D) units of the NYP hospital system implemented universal SARS-CoV-2 testing of all delivering patients by nasopharyngeal PCR on 3/22/2020 and by serological testing for antibodies on 7/20/2020. Additional symptom-based testing occurred throughout pregnancy and results obtained from external testing sites were recorded in the EHR when possible. For each mother with a positive SARS-CoV-2 PCR and/or serology test during pregnancy (defined based on last menstrual period and delivery date) identified by automated EHR extraction, a careful chart review was conducted to determine the date of symptom onset, which was then referenced to infant GA to determine the trimester of in utero exposure. Exact exposure timing was determined for 79 of 107 mothers (74%) included in this analysis. For 28 (26%) asymptomatic serology-positive mothers, an exact date of symptom onset could not be determined, so the date with the peak number of SARS-CoV-2 infections during the first wave of the pandemic in NYC (4/6/2020) was used to impute the trimester of exposure. SARS-CoV-2 infection severity was categorized as asymptomatic, mild (defined as nonpneumonia or mild pneumonia) or severe (defined as dyspnea, respiratory rate ≥30/min, blood oxygen saturation≤93%, partial pressure of arterial oxygen to fraction of inspired oxygen ratio<300, and/or lung infiltrates>50% within 24-48 hours 16 ).

Based on EHR and/or maternal-report, five infants in the pandemic cohort and zero infants in the historical cohort were infected with SARS-CoV-2 between birth and the neurodevelopmental assessment.

Between 5 months, 0 days, and 6 months, 30 days (186.79±11.75 days), infant neurodevelopment was assessed by maternal-report using the Ages & Stages Questionnaire, 3 rd Edition (ASQ-3) in English or Spanish via secure REDCap survey. The ASQ-3 was completed between October, 2020 and June, 2021 for the pandemic cohort and between May, 2018 and July, 2020 for the historical cohort. The ASQ-3 is a validated, widely used, standardized, level 1 screening tool based on parental-report that reliably assesses five key developmental domains: communication, fine and gross motor, problem solving, and personal-social skills. The ASQ-3 has strong concurrent validity (r=0.85), two-week test-retest reliability (r=0.75-0.82), inter-observer reliability (r=0.43-0.69), and internal consistency (α=0.51-0.87) 39, 40 .

Statistical analyses were conducted in R version 4.0.2. The experimental design (forced-choice online survey and chart review) resulted in no missingness. Power analyses were based on the primary outcome investigating mean differences in ASQ-3 subdomain scores between infants with and without in utero exposure to maternal SARS-CoV-2 infection using analyses of covariance (ANCOVAs), for which we had 90% power to detect a 0.5 SD difference in each subdomain using a two-sided test with alpha0.05 (see Supplementary Materials). Within the exposed subset, we also examined the effect of SARS-CoV-2 timing and severity on ASQ-3 subdomains via ANCOVA. For secondary analyses, ANCOVAs were used to determine mean differences in ASQ-3 subdomains between the pandemic and historical cohorts. For both primary and secondary analyses, we implemented minimally (GA at birth, infant sex, and infant age at assessment) and fully adjusted models (additionally controlled for maternal race, ethnicity, age at delivery, educational attainment, parity, and mode of delivery). Percentages of infants screening below cutoffs indicative of delays per ASQ-3 developers 39 were computed for each subdomain and for overall ASQ-3. Fisher's Exact Test was used to examine group differences in screening positive for delays between the pandemic and historical cohorts. For ASQ-3 subdomains where a significant main effect was identified, tertiary analyses examined scores in relation to trimester of pregnancy during peak NYC SARS-CoV-2 cases (4/6/2020) using fully adjusted ANCOVA models with general linear hypothesis testing using Tukey pairwise contrasts.

Mean differences with confidence intervals (95% CI) are reported for all significant main effects. Estimated marginal means are reported in supplemental tables. Significance was set at p<0.05.

Highlighting the disproportionate impact of COVID-19 on already medically disadvantaged groups, SARS-CoV-2 infected mothers significantly differed from non-infected mothers in their selfreported race (X 2 =18.33, p=0.005), ethnicity (X 2 =21.07, p<0.001), and education attainment (X 2 =21.80, p=0.001), with a higher proportion identifying as other or mixed race (34.6% versus 21.4%) and Hispanic or Latino/a/x or Spanish ethnicity (64.5% versus 38.9%) and a lower proportion reporting a graduate degree (16.8% versus 40.5%) ( Table 1 ). Compared to the pandemic cohort, the historical cohort significantly differed in race (X 2 =51.04, p<0.001), ethnicity (X 2 =37.85, p<0.001), education attainment (X 2 =35.17, p<0.001), and mode of delivery (X 2 =16.95, p<0.001). Group differences were accounted for in all fully adjusted models.

There were no significant group differences between exposed and unexposed infants in any of the five ASQ-3 subdomain scores (communication, gross motor, fine motor, problem solving, or personal-social) at 6-months ( Figure 1A ) in either minimally or fully adjusted models ( Table 2 ). The majority of mothers experienced asymptomatic (36%) or mild disease (61%) and were infected in the second (48%) or third (33%) trimester (Supplemental Table S1 ). A small proportion of mothers had severe disease (4%) and 20% were infected in the first trimester. Neither All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint symptom severity nor timing of infection showed an association to any ASQ-3 subdomain score in either minimally or fully adjusted models (Supplemental Table S2 and S3). 

Our primary analysis revealed no associations between SARS-CoV-2 status, timing, or severity and ASQ-3 scores. Therefore, exposed and unexposed infants in the pandemic cohort were pooled together and compared to infants in the historical cohort. Compared to those in the historical cohort, infants in the pandemic cohort had significantly lower mean scores on the gross motor (mean difference -5. between birth and ASQ-3 assessments did not alter findings (Supplemental Table S5 and S6). Sensitivity analyses excluding 15 infants in the historical cohort who were assessed during the pandemic did not alter findings on fine and gross motor scores, but personal-social scores no longer differed significantly between cohorts (Supplemental Table  S7 ).

Though not specifically powered to detect differences in the proportion of infants who met screening cutoffs for delay, a greater proportion of infants in the pandemic cohort met the gross motor cutoff (one-sided Fisher's, p=0.01) ( Table 2) .

We investigated whether the timing of pregnancy relative to the peak of the pandemic in NYC was associated with scores on the ASQ-3 subdomains that were identified as different between the pandemic and historical cohorts using fully adjusted models. There was a significant effect of trimester of pregnancy on fine motor (F3, 277=6.04, p=0.0005, n 2 = 0.016) and gross motor scores (F3, 277=5.34, p=0.001, n 2 = 0.012). However, Tukey All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint contrasts did not reach the significance threshold (p>.05) (Supplemental Table S8 and S9). There was also a significant effect of trimester of pregnancy on infant personal-social scores (F3, 277=4.05, p= 0.007, n 2 = 0.025). Compared to historic controls, infants born to mothers who were in their first trimester of pregnancy during the peak of the pandemic had a significant reduction in personal-social scores (mean difference -6.16, 95% CI [-12.22, -0.10], p=0.009) (Figure 2 , Supplemental Table S8 and S10).

The clinical and research communities have emphasized the critical need for information regarding the neurodevelopmental effects of fetal exposure to maternal SARS-CoV-2 infection 27-31 . Prior studies of the association between fetal exposure to maternal viral infections, MIA, and atypical child neurodevelopment, led to the speculation that maternal SARS-CoV-2 infection during pregnancy may be associated with global developmental delays or specific neurodevelopmental disorders 27-31 . To our knowledge, our analysis is the first to examine this association and, contrary to the proposed hypothesis, we did not find an association between maternal SARS-CoV-2 infection status, timing, or severity and infant neurodevelopment at 6-months of age as measured using a standardized screener. However, infants born during the pandemic, regardless of maternal SARS-CoV-2 status, scored significantly lower on the gross motor, fine motor, and personalsocial subdomains of the ASQ-3 when compared to a historical cohort of infants born at the same institution at least two months prior to the start of the pandemic. Furthermore, early gestation at the peak of the pandemic in NYC was associated with lowest personal-social scores compared to historic controls. Taken together, these findings suggest the potential for a significant public health impact on the generation born during the COVID-19 pandemic, necessitating further investigation.

Despite little evidence that coronaviruses, such as SARS-CoV, MERS-CoV, and now SARS-CoV-2, can cross the placenta 41, 42 , the speculation that in utero SARS-CoV-2 exposure may impact infant neurobehavior was based on the established role of MIA on fetal brain development and fueled by recent findings of increased interleukin-6 (IL-6) in SARS-CoV-2-infected pregnant women 43 . In animal models of MIA, both viral exposure and direct injection of IL-6 lead to dose-dependent atypical behavior in offspring 44, 45 . Although SARS-CoV-2 severity during pregnancy is positively correlated with IL-6 levels 43 , our analysis did not reveal an association between severity and ASQ-3 scores. It should be noted that the majority of our 

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint participants experienced an asymptomatic or mild SARS-CoV-2 infection, and therefore, infants exposed to significant MIA may not be represented in our data. Similarly, early gestational exposure is most likely to be associated with adverse neurodevelopmental outcomes [46] [47] [48] . Given that only 21 maternal SARS-Cov-2 infections (8 imputed) in our sample occurred in the first trimester, our results provide limited power for detecting the effects of infection at this early timepoint.

Together, the lack of neurodevelopmental differences between in utero SARS-CoV-2 exposed and unexposed infants and the observed group differences between the historical and pandemic cohorts suggest COVID-19-related stress should be considered as a potential underlying mechanism. Reported stressors have included job loss, food insecurity, and loss of housing, 49 and the pandemic has resulted in significant increases in symptoms of anxiety and depression 50 . Consistent with our finding that infants born to women who were in the first trimester of pregnancy during the pandemic peak had the greatest reduction in personal-social scores, data from numerous cohort studies have demonstrated that prenatal perceived stress, loneliness, and objective stress, especially during early gestation, are associated with increased risk for adverse neurodevelopment in children 3,51-59 . Although consistent with prior studies of children born during natural disasters, interpretation of our results should take into account several limitations. The data included in this analysis represent a single center, which may impact generalizability. Critically, it is also possible that developmental outcomes beyond 6-months of age will show different patterns as this is a relatively early timepoint. The ASQ-3 has modest agreement with objective measures of development 60,61 and is often used by general pediatricians 62 . However, as a parent-report measure, our results may reflect parental-perception ofrather than objective differences ininfant neurodevelopment. Nonetheless, parental perception of development also has implications for long-term child outcomes 63 . Notable strengths of our study include detailed medical records on maternal SARS-CoV-2 status, timing, and severity, and availability of a historical comparison group from the same hospital center using the same neurodevelopmental assessment.

This first analysis of the neurodevelopment of infants born during the COVID-19 pandemic (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Drs. Gyamfi-Bannerman, Dumitriu, Stockwell, and Mourad receive funding from the Centers for Disease Control and Prevention for COVID-19-related mother-infant research. Drs. Gyamfi-Bannerman and Dumitriu have pending reimbursement for consulting for Medela Inc.

Our power analyses were based on our primary outcome, which aimed to investigate mean ASQ-3 subdomain score differences between infants with and without in utero exposure to maternal SARS-CoV-2 infections. The developers of the ASQ-3 recommend referral for infants and children scoring less than or equal to 2.0 standard deviations (SD) below normative means on any of the five subdomains. They further recommend monitoring and possible referral for infants and children scoring between 1.0 and 2.0 SD below normative means. Based on their published data, 6-month normative values are (meanSD): 48.909.63 for communication, 45.6411.69 for gross motor, 48.9311.90 for fine motor, 50.4111.30 for problem solving and 48.3111.48 for personal-social. Using these normative values, our power analysis aimed to ensure 90% power to detect a 0.5 SD difference between groups, with alpha set to <0.05. Given COMBO's enrollment has an approximate 1:1 ratio, achieving this requires a sample size of a minimum of 166 infants for problem solving and a minimum of 168 infants for all other subdomains. The current manuscript includes a total of 238 COMBO infants and therefore our analyses were well-powered to detect differences in mean ASQ-3 subdomain scores of at least 0.5 SD between SARS-CoV-2 exposed versus unexposed infants.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint Severe 0 (0) 0 (0) 0 (0) 0 (0) 4 (12.5) 4 (11.4) All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint Minimally adjusted models included GA at birth, infant sex, and infant age at assessment. Fully adjusted models additionally controlled for maternal race, ethnicity, age at delivery, educational attainment, parity, mode of delivery, and gestational timing of SARS-CoV-2 infection.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint Minimally adjusted models included GA at birth, infant sex, and infant age at assessment. Fully adjusted models additionally controlled for maternal race, ethnicity, age at delivery, educational attainment, parity, mode of delivery, and gestational timing of SARS-CoV-2 infection.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint Table S10. Estimated marginal means of personal-social scores by trimester of pregnancy relative to peak SARS-CoV-2 cases in NYC (based on fully adjusted model) All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.12.21260365 doi: medRxiv preprint

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery

Normal development of brain circuits

Prenatal Developmental Origins of Future Psychopathology: Mechanisms and Pathways

DOHaD at the intersection of maternal immune activation and maternal metabolic stress: a scoping review

Growth of children according to maternal and child HIV, immunological and disease characteristics: A prospective cohort study in Kinshasa, Democratic Republic of Congo

Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study

Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana

HIVexposed, uninfected infants: New global challenges 9

in the era of paediatric HIV elimination. The Lancet Infectious Diseases

HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study

Child Growth According to Maternal and Child HIV Status in Zimbabwe

Maternal Perinatal HIV Infection Is Associated With Increased Infectious Morbidity in HIVexposed Uninfected Infants

Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town

A description of early neurodevelopment in a cohort of HIV-exposed uninfected children

Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework

Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center

A review of newborn outcomes during the COVID-19 pandemic

Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis

Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. The Lancet Child & Adolescent Health

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Pregnancy In China: A Retrospective Cohort Study

Is the 1918 Influenza Pandemic Over? Long-Term Effects of In Utero Influenza Exposure in the Post-1940 U.S. Population

Neurodevelopmental Disorders Induced by Maternal Immune Activation: Toward a Prevention Strategy in the Era of the COVID-19 Pandemic

COVID-19 during pregnancy: Potential risk for neurodevelopmental disorders in neonates?

COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research

Does Lack of Vertical Transmission of COVID-19 Guarantee the Health of the Fetus or Neonate in Infected Mothers?

COVID-19 and Pregnancy: Time to Think beyond Medications

Inflammatory cytokines induced by severe acute respiratory syndrome coronavirus 2 infection during pregnancy may alter fetal brain development predisposing the offspring to neurodevelopmental disorders

Very Early Identification and Intervention for Infants at Risk of Neurodevelopmental Disorders: A Transdiagnostic Approach

Efficacy of early interventions for infants and young children with, and at risk for, autism spectrum disorders

Early diagnosis of autism and impact on prognosis: a narrative review

Early gross motor skills predict the subsequent development of language in children with autism spectrum disorder

Early motor abilities in infants at heightened versus low risk for ASD: A Baby Siblings Research Consortium (BSRC) study

Infection prevention and control for labor and delivery, well baby nurseries, and neonatal intensive care units

Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China

Measurement framework for the Environmental influences on Child Health Outcomes research program

Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s

The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective casecontrol study

Maternal immune activation alters fetal brain development through interleukin-6

Infections and Brain Development

Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies

Maternal influences on fetal brain development: The role of nutrition, infection and stress, and the potential for intergenerational consequences

Pandemic: An Update. Kaiser Family Foundation, 2021. (Accessed 5/30/21

Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic -United States

The persisting effect of maternal mood in pregnancy on childhood psychopathology

Prenatal developmental origins of behavior and mental health: The influence of maternal stress in pregnancy

Risk of cognitive impairment in children after maternal exposure to the 1998 Yangtze River flood during pregnancy: analysis of data from China's second National Sample Survey on Disability

Maternal loneliness: concurrent and longitudinal associations with depressive symptoms and child adjustment

Prenatal stress and cognitive development and temperament in infants

Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events

Prenatal maternal stress predicts autism traits in 6½ year-old children: Project Ice Storm

Comparative Accuracy of Developmental Screening Questionnaires

Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance and Screening

The potential impact of the COVID-19 pandemic on child growth and development: a systematic review

The authors are grateful for the institutional support provided by the Maternal-Child Research Oversight (MaCRO) Committee and the Departments of